Research study Program year 2020 Source: CMS Open Payments

M14-031

ClinicalTrials.gov NCT02755597

Research payments

$436,577

96 payments

Through program year 2020, $436,577 in research payments was reported against M14-031, across 96 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT02755597

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$126,871	47
2019	Research	$309,706	49

Breakdown

Who paid Research payments · program years 2019–2020

AbbVie, Inc. $436,577 96 payments

Who received the money Research payments · program years 2019–2020

Parameswaran Hari Hematology & Oncology · Milwaukee, WI $117,475 5 payments
Jacalyn Rosenblatt Hematology · Boston, MA $64,030 5 payments
Duke University Organisation paid for research $57,066 18 payments
Joseph Mikhael Hematology · Scottsdale, AZ $43,560 6 payments
Massachusetts General Physician Organisation paid for research $42,195 5 payments
Arthur Rabinowitz Hematology · Burlington, MA $32,285 7 payments
University of Colorado Denver School of Medicine Organisation paid for research $27,208 7 payments
Jeffrey Zwicker Hematology · New York, NY $18,665 6 payments
David Avigan Hematology & Oncology · Boston, MA $17,145 5 payments
Gabrail Cancer Center Organisation paid for research $5,304 8 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.